Trichomonas Vaginalis a Review of Epidemiologic Clinical and Treatment Issues

Review

doi: x.1186/s12879-015-1055-0.

Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues

Affiliations

• PMID: 26242185
• PMCID: PMC4525749
• DOI: ten.1186/s12879-015-1055-0

Gratuitous PMC commodity

Review

Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues

Patricia Kissinger . BMC Infect Dis. 2015 .

Complimentary PMC article

Abstract

Trichomonas vaginalis (Idiot box) is likely the nearly mutual not-viral sexually transmitted infection (STI) in the earth. It is equally an of import source of reproductive morbidity, a facilitator of HIV transmission and acquisition, and thus it is an important public health trouble. Despite its importance in homo reproductive health and HIV transmission, it is not a reportable illness and surveillance is non generally done. This is problematic since virtually persons infected with TV are asymptomatic. Metronidazole (MTZ) has been the treatment of choice for women for decades, and single dose has been considered the first line of therapy. Still, high rates of retest positive are found amidst TV infected persons after single dose MTZ treatment. This has non been explained by drug resistance since in vitro resistance is only 2-5 %. Treatment failure can range from 7-10 % and even higher among HIV+ women. Handling efficacy may be influenced by vaginal ecology. The origins of repeat positives need further explanation and better treatment options are needed.

Figures

Fig. 1

Possible causes of a repeat TV+ test after treatment among TV infected persons

Similar articles

• A randomized handling trial: single versus seven-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.

  Kissinger P, Mena Fifty, Levison J, Clark RA, Gatski K, Henderson H, Schmidt N, Rosenthal SL, Myers 50, Martin DH. Kissinger P, et al. J Acquir Immune Defic Syndr. 2010 Dec fifteen;55(5):565-71. doi: 10.1097/QAI.0b013e3181eda955. J Acquir Immune Defic Syndr. 2010. PMID: 21423852 Free PMC commodity. Clinical Trial.

• Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.

  Seña Air-conditioning, Bachmann LH, Hobbs MM. Seña AC, et al. Expert Rev Anti Infect Ther. 2014 Jun;12(6):673-85. doi: ten.1586/14787210.2014.887440. Epub 2014 February 20. Adept Rev Anti Infect Ther. 2014. PMID: 24555561 Review.

• Added benefit of nucleic acrid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic.

  Muzny CA, Blackburn RJ, Sinsky RJ, Austin EL, Schwebke JR. Muzny CA, et al. Clin Infect Dis. 2014 Sep 15;59(6):834-41. doi: 10.1093/cid/ciu446. Epub 2014 Jun 13. Clin Infect Dis. 2014. PMID: 24928292

• Patient-delivered partner treatment and Trichomonas vaginalis echo infection amidst human immunodeficiency virus-infected women.

  Gatski M, Mena L, Levison J, Clark RA, Henderson H, Schmidt N, Rosenthal SL, Martin DH, Kissinger P. Gatski M, et al. Sex activity Transm Dis. 2010 Aug;37(viii):502-5. doi: 10.1097/OLQ.0b013e3181d891fc. Sex Transm Dis. 2010. PMID: 20502393 Free PMC article. Clinical Trial.

• Trichomonas vaginalis polymerase concatenation reaction compared with standard diagnostic and therapeutic protocols for detection and handling of vaginal trichomoniasis.

  Wendel KA, Erbelding EJ, Gaydos CA, Rompalo AM. Wendel KA, et al. Clin Infect Dis. 2002 Sep 1;35(5):576-80. doi: ten.1086/342060. Epub 2002 Aug vi. Clin Infect Dis. 2002. PMID: 12173132

Cited by 76 articles

• Molecular label of Trichomonas infections in women of Ilam City, southwestern Iran.

  Alikhani 1000, Akhoundi M, Sereno D, Abdi J, Naserifar R, Mahmoudi MR, Mirzaei A. Alikhani M, et al. Parasitol Res. 2022 Mar 25. doi: x.1007/s00436-022-07492-west. Online ahead of impress. Parasitol Res. 2022. PMID: 35332380

• Kinetic and Molecular Docking Studies to Determine the Effect of Inhibitors on the Activeness and Construction of Fused G6PD::6PGL Protein from Trichomonas vaginalis.

  Martínez-Rosas V, Hernández-Ochoa B, Navarrete-Vázquez Yard, Martínez-Conde C, Gómez-Chávez F, Morales-Luna 50, González-Valdez A, Arreguin-Espinosa R, Enríquez-Flores S, Pérez de la Cruz Five, Aguayo-Ortiz R, Wong-Baeza C, Baeza-Ramírez I, Gómez-Manzo S. Martínez-Rosas V, et al. Molecules. 2022 Feb nine;27(4):1174. doi: 10.3390/molecules27041174. Molecules. 2022. PMID: 35208965 Free PMC commodity.

• Thio- and selenosemicarbazones every bit antiprotozoal agents against Trypanosoma cruzi and Trichomonas vaginalis.

  Ibáñez-Escribano A, Fonseca-Berzal C, Martínez-Montiel G, Álvarez-Márquez M, Gómez-Núñez M, Lacueva-Arnedo M, Espinosa-Buitrago T, Martín-Pérez T, Escario JA, Merino-Montiel P, Montiel-Smith South, Gómez-Barrio A, López Ó, Fernández-Bolaños JG. Ibáñez-Escribano A, et al. J Enzyme Inhib Med Chem. 2022 Dec;37(1):781-791. doi: 10.1080/14756366.2022.2041629. J Enzyme Inhib Med Chem. 2022. PMID: 35193444 Costless PMC commodity.

• Vaginal trichomoniasis.

  Cenkowski M, Wudel B, Poliquin Five. Cenkowski One thousand, et al. CMAJ. 2022 Feb fourteen;194(6):E217. doi: 10.1503/cmaj.211088. CMAJ. 2022. PMID: 35165134 Free PMC article. No abstract available.

• Ultrastructural and Functional Analysis of a Novel Extra-Axonemal Structure in Parasitic Trichomonads.

  Coceres VM, Iriarte LS, Miranda-Magalhães A, Santos de Andrade TA, de Miguel N, Pereira-Neves A. Coceres VM, et al. Front Cell Infect Microbiol. 2021 Nov 9;xi:757185. doi: 10.3389/fcimb.2021.757185. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34858875 Gratis PMC article.

References

1. 1. World Health Organization W. Global incidence and prevalence of selected curable sexually transmitted infections. 2008. ISBN 978 92 4 150383 9
2. 1. World Wellness O. Global prevalence and incidence of selected curable sexually transmitted infections: overviews and estimates. In: WHO/ HIV_AIDS. Edited by Organization WH. Geneva; 2001.
3. 1. Miller WC, Swygard H, Hobbs MM, Ford CA, Handcock MS, Morris M, Schmitz JL, Cohen MS, Harris KM, Udry JR. The prevalence of trichomoniasis in young adults in the United states. Sexual activity Transm Dis. 2005;32(10):593–598. doi: ten.1097/01.olq.0000179874.76360.ad. - DOI - PubMed
4. 1. Sutton Thousand, Sternberg M, Koumans EH, McQuillan Grand, Berman S, Markowitz L. The prevalence of Trichomonas vaginalis infection amidst reproductive-age women in the United States, 2001–2004. Clin Infect Dis. 2007;45(x):1319–1326. doi: ten.1086/522532. - DOI - PubMed
5. 1. Gregson South, Stonemason PR, Garnett GP, Zhuwau T, Nyamukapa CA, Anderson RM, Chandiwana SK. A rural HIV epidemic in Zimbabwe? Findings from a population-based survey. Int J STD AIDS. 2001;12(3):189–196. doi: ten.1258/0956462011917009. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • BioMed Cardinal
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • Faculty Opinions
  • The Lens - Patent Citations
  • scite Smart Citations

• Medical

  • ClinicalTrials.gov
  • MedlinePlus Health Information

milleronsing.blogspot.com

Source: https://pubmed.ncbi.nlm.nih.gov/26242185/

Share this post